GE Wireless Maternal-Fetal Monitor OKd for ~ 95% of All Eligible US Births

 

• GE HealthCare receives FDA clearance for expanded indication for Novii+ maternal and fetal monitoring solution for pregnant patients ≥34 weeks.
• Novii+ noninvasively measures and displays fetal heart rate, maternal heart rate and uterine activity, while providing patient comfort and mobility in the hospital.

https://www.businesswire.com/news/home/20240201621167/en/